Perspective from the heartland: Cancer care and research during a public health crisisMarch 26, 2020COVID-19 UpdatesBreast CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung Cancer
Cancer care and COVID-19 in Seattle, the first U.S. epicenterMarch 23, 2020COVID-19 UpdatesCNS/Brain CancerBreast CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
How is oncology adapting to COVID-19?March 23, 2020COVID-19 UpdatesBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Disruptions in cancer care in the era of COVID-19March 20, 2020COVID-19 UpdatesPatient & Survivor CareBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic Cancer
Largest meeting on cancer research canceled: AACRMarch 11, 2020Mixed TopicsLung CancerHead & Neck/Thyroid CancersGynecologic CancerGenitourinary CancerGastroenterologyCNS/Brain Cancer
Late effects in young cancer survivors underscore importance of high-risk screeningFebruary 21, 2020Mixed TopicsLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersSarcoma & GISTRenal Cell CarcinomaCNS/Brain CancerGenitourinary Cancer
FDA: Cell phones still look safeFebruary 11, 2020Mixed TopicsCNS/Brain CancerBreast CancerLung CancerLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationGynecologic Cancer
CRISPR-engineered T cells may be safe for cancer, but do they work?February 6, 2020Sarcoma & GISTLymphoma & Plasma Cell Disorders
Global project reveals cancer’s genomic playbookFebruary 5, 2020Mixed TopicsCNS/Brain CancerBreast CancerLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHead & Neck/Thyroid CancersGynecologic Cancer
FDA approves first treatment for advanced epithelioid sarcomaJanuary 24, 2020Sarcoma & GISTRare Diseases
T-VEC plus pembrolizumab yields promising response rate in phase 2 sarcoma studyJanuary 24, 2020Sarcoma & GISTImmuno-oncology
FDA approves avapritinib for adults with GIST with PDGFRA mutationJanuary 10, 2020GastroenterologySarcoma & GISTGastrointestinal Cancer
Rozlytrek approved for ROS1-positive metastatic NSCLC, cancers with NTRK gene fusion defectsAugust 15, 2019Lung CancerSarcoma & GIST
FDA approves Turalio for symptomatic tenosynovial giant cell tumorAugust 2, 2019Sarcoma & GISTRare Diseases
EHR default order slashes unnecessary imaging during palliative RTJune 28, 2019Practice ManagementCNS/Brain CancerSarcoma & GIST
